SHANGHAI, Dec. 18, 2018 /PRNewswire/ -- Pall Corporation, the global leader of advanced filtration, separation and purification technologies, has established a Biotech Integrated Solutions Center of Excellence (CoE) in Shanghai, China. Strategically located in the heart of Shanghai's renowned life science cluster, the CoE is a new state-of-the-art facility for bioprocess engineering consultancy, technology demonstration, testing and training for China and broader Asia. An opening ceremony was held today.
Equipped with advanced bioprocessing equipment and automation platforms, the CoE showcases the latest end-to-end technological solutions for biomanufacturing, including single-use cell culture solutions, cell clarification using acoustic wave technology, chromatography using automated packing techniques, viral clearance, tangential flow filtration and mixer / container modules. It is designed to lead Pall's customers through the sequential stages of process flow and will serve as a proving ground for new technologies, as well as a training facility for Pall customers and Pall employees.
"As the biopharmaceutical industry moves from traditional batch or single-use processing to continuous bioprocessing solutions, Pall is poised to help customers reduce process development and production costs and drive significant improvements in efficacy and productivity," President of Pall Corporation, Jennifer Honeycutt, explained.
"Our investment in the new Shanghai Centre of Excellence is designed to give Pall customers options ranging from batch to single use and continuous bioprocessing solutions, depending upon where customers are in their journey. The goal is to provide technology solutions that meet their current needs, while offering some of the most progressive technological solutions for the future," added Honeycutt. "By opening this state-of-the-art facility, we hope to unlock new opportunities for our customers based in China, and for any global customers looking to enter or expand their operations in the Asia Pacific region."
Pall Biotech has invested heavily in a growing network of CoE facilities worldwide to support its global biopharmaceutical customer base. Three CoE facilities currently exist in Portsmouth (UK), Westborough (USA), and Shanghai (China), with planning for a new European facility in process.
Pall Corporation is a filtration, separation and purification leader providing solutions to meet the critical fluid management needs of customers across the broad spectrum of life sciences and industry. Pall works with customers to advance health, safety and environmentally responsible technologies. The Company's engineered products enable process and product innovation and minimize emissions and waste. Pall Corporation serves customers worldwide. Follow more information visit www.pall.com or www.pall.cn.
Pall Corporation Media Contact:
Pall China Media Contact:
Strategic Marketing Director – Pall China
+86 159 0090 9130
SOURCE Pall Corporation